ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,527, issued on June 23, was assigned to Ablynx NV (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris).
"Serum albumin binding immunoglobulin single variable domains" was invented by Stephanie Staelens (Wevelgem, Belgium), Soren Steffensen (Etterbeek, Belgium), Erika Morizzo (Cambridge, Great Britain), Raf Ponsaerts (Kampenhout, Belgium), Ingrid Ottevaere (Nazareth, Belgium) and An Cerdobbel (Nevele, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain ...